Biomedical Bulletin Newsletters

  1. April 2026
  2. December 2025
  3. September 2025
  4. June 2025
  5. April 2025
  6. December 2024
  7. September 2024
  8. July 2024
  9. February 2024
  10. November 2023
  11. July 2023
  12. April 2023

Press Releases

  1. February 19, 2026 – (Biovia) – SwiftPharma announces partnership with Medicines Patent Pool and Population Council on Project ELYRA to expand pathways for Griffithsin-based STI prevention
  2. February 4, 2026 – Contraline and Population Council Execute Global Exclusive License Agreement for NES/T Male Contraception Gel
  3. December 8, 2025 – Dapivirine Vaginal Ring price drops by over 50%, bringing more affordable HIV prevention options to women and adolescent girls in Africa and beyond
  4. July 30,2025 – Contraline Exercises License Option for NES/T, the First Male Contraceptive to Reach Late-Stage Development
  5. June 26, 2025 – Dapivirine Vaginal Ring Recommended as an HIV Prevention Option for Adolescent Girls 
  6. October 7, 2024 – (IPM 054) – 3-Month Dapivirine Vaginal Ring for HIV Prevention Demonstrates Superior Drug Release Compared to 1-Month Ring
  7. September 11, 2024 – (Contraline) – Contraline & Population Council Announce Option-to-License Agreement for a Revolutionary Male Contraceptive
  8. September 10, 2024 – (Médunik Canada) – Médunik Canada and the Population Council join in a research partnership for a potential new treatment for multiple sclerosis
  9. August 26, 2024 – (FLAS) – Eswatini to roll out first women-controlled HIV prevention product
  10. July 21, 2024 – (CIFF & Global Fund) – CIFF To Propel PrEP Revolution with up to US$2 Million for Immediate Access to PrEP Rings
  11. February 20, 2024 – (Exeltis) – The Population Council’s Center for Biomedical Research Enters Agreement with Exeltis to Develop a Non-Hormonal Multipurpose Intravaginal Ring
  12. November 30, 2023 – (Burness) – Innovative HIV Prevention Product for Women that Promotes Choice – Dapivirine Vaginal Ring (DVR) – Gains Momentum Across Africa
  13. November 14, 2023 – (Grand Challenges Canada) – Population Council Awarded Grand Challenges Canada Grant to Support the Market Introduction of the Dapivirine Vaginal Ring
  14. September 12, 2023 – (Celanese Agreement) – Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic
  15. September 8, 2023 – (SwiftPharma Agreement) – SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV
  16. March 13, 2023 – (German PDP) – German Federal Ministry of Education and Research (BMBF) Grant through KfW Development Bank awards Population Council €10 million
  17. October 19, 2022 – (IPM Acquisition) – Population Council and Imres BV Announce Partnership Agreement for Global Distribution of the Monthly Dapivirine Vaginal Ring
  18. October 4, 2022 – (IPM Acquisition) – Population Council Completes Asset Purchase Agreement from the International Partnership for Microbicides, Acquiring the Monthly Dapivirine Ring and Other HIV Prevention Technologies
  19. July 21, 2022 – (IPM Acquisition) – Population Council Acquires the Monthly Dapivirine Ring and Other Woman-centered HIV Prevention Technologies from the International Partnership for Microbicides
  20. January 27, 2022 – (P50) – NIH Center Grant to Develop First Non-Hormonal Vaginal Ring for Pregnancy and STI Prevention
  21. January 27, 2022 – (M360) – Medicines360 and the Population Council Pursue Agreement to Develop Product to Prevent HIV and Unintended Pregnancy for Worldwide Distribution

Center for Biomedical Research (CBR)